These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32561396)

  • 1. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy.
    Xu D; Zhang X; Chen X; Yang S; Chen H
    Life Sci; 2020 Sep; 256():117980. PubMed ID: 32561396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR-141-mediated NLRP3 inflammasome and TGF-β1/Smads signaling in diabetic cardiomyopathy.
    Che H; Wang Y; Li H; Li Y; Sahil A; Lv J; Liu Y; Yang Z; Dong R; Xue H; Wang L
    FASEB J; 2020 Apr; 34(4):5282-5298. PubMed ID: 32067273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
    Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
    Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway.
    Li X; Li Z; Li B; Zhu X; Lai X
    Life Sci; 2019 Oct; 234():116773. PubMed ID: 31422095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR.
    Xu Y; Fang H; Xu Q; Xu C; Yang L; Huang C
    Cell Cycle; 2020 Nov; 19(22):3054-3065. PubMed ID: 33092444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation.
    Zhang H; Chen X; Zong B; Yuan H; Wang Z; Wei Y; Wang X; Liu G; Zhang J; Li S; Cheng G; Wang Y; Ma Y
    J Cell Mol Med; 2018 Sep; 22(9):4437-4448. PubMed ID: 29993180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy.
    Sun X; Sun X; Meng H; Wu J; Guo X; Du L; Wu H
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of ROS/Chloride Efflux-Mediated NLRP3 Inflammasome Activation Contributes to Alleviation of Diabetic Cardiomyopathy in Rats after Sleeve Gastrectomy.
    Li S; Dong S; Shi B; Xu Q; Li L; Wang S; Zhang W; Zhong M; Zhu J; Cheng Y; Zhang G; Hu S
    Oxid Med Cell Longev; 2022; 2022():4608914. PubMed ID: 35498125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathelicidin-WA ameliorates diabetic cardiomyopathy by inhibiting the NLRP3 inflammasome.
    Peng M; Liu Y; Xu Y; Li L; Li Y; Yang H
    Cell Cycle; 2021 Nov; 20(21):2278-2290. PubMed ID: 34585633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.
    Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of HDAC6 alleviates ventricular remodeling in experimental dilated cardiomyopathy via inhibition of NLRP3 inflammasome activation and promotion of cardiomyocyte autophagy.
    Pang X; Guan Q; Lin X; Chang N
    Cell Biol Toxicol; 2023 Oct; 39(5):2365-2379. PubMed ID: 35764897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of microRNA-15 protects H9c2 cells against CVB3-induced myocardial injury by targeting NLRX1 to regulate the NLRP3 inflammasome.
    Tong R; Jia T; Shi R; Yan F
    Cell Mol Biol Lett; 2020; 25():6. PubMed ID: 32099552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Invasive Local Acoustic Therapy Ameliorates Diabetic Heart Fibrosis by Suppressing ACE-Mediated Oxidative Stress and Inflammation in Cardiac Fibroblasts.
    Weng L; Li L; Zhao K; Xu T; Mao Y; Shu H; Chen X; Chen J; Wu J; Guo X; Tu J; Zhang D; Sun W; Kong X
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):413-424. PubMed ID: 35156147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
    Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
    Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
    Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
    Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid 2 Receptor Activation Protects against Diabetic Cardiomyopathy through Inhibition of AGE/RAGE-Induced Oxidative Stress, Fibrosis, and Inflammasome Activation.
    Hashiesh HM; Azimullah S; Nagoor Meeran MF; Saraswathiamma D; Arunachalam S; Jha NK; Sadek B; Adeghate E; Sethi G; Albawardi A; Al Marzooqi S; Ojha S
    J Pharmacol Exp Ther; 2024 Oct; 391(2):241-257. PubMed ID: 38955492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy.
    Yang F; Qin Y; Wang Y; Meng S; Xian H; Che H; Lv J; Li Y; Yu Y; Bai Y; Wang L
    Int J Biol Sci; 2019; 15(5):1010-1019. PubMed ID: 31182921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of NLRP3 gene knockdown on pyroptosis and ferroptosis in diabetic cardiomyopathy injury.
    Wang J; Li Y; Li L; Liang H; Ye H; Kang P; Li Z; Yu Y; Gao Q
    BMC Cardiovasc Disord; 2024 Jul; 24(1):351. PubMed ID: 38987672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.
    Chen H; Tran D; Yang HC; Nylander S; Birnbaum Y; Ye Y
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):443-461. PubMed ID: 32335797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.